Nathanael Gray

Co-Founder at Syros Pharmaceuticals, Inc.

Nathanael Gray

Nathanael Gray

Co-Founder at Syros Pharmaceuticals, Inc.

Overview
Career Highlights

Syros Pharmaceuticals, Inc.
Petra Pharma Corp.
C4 Therapeutics, Inc.

RelSci Relationships

1881

Number of Boards

2

Relationships
RelSci Relationships are individuals Nathanael Gray likely has professional access to. A relationship does not necessarily indicate a personal connection.

President at Novartis Institutes for BioMedical Research, Inc.

Relationship likelihood: Strong

President & Chief Executive Officer at Syros Pharmaceuticals, Inc.

Relationship likelihood: Strong

Faculty Member at Whitehead Institute for Biomedical Research

Relationship likelihood: Strong

Director, Epigenomics Program at The Broad Institute, Inc.

Relationship likelihood: Strong

Head, Research & Early Development at Genentech, Inc.

Relationship likelihood: Strong

Member, Scientific Advisory Board at Syros Pharmaceuticals, Inc.

Relationship likelihood: Strong

Member, Scientific Advisory Board at Circle Pharma, Inc.

Relationship likelihood: Strong

Chief Scientific Officer & Co-Founder at Relay Therapeutics, Inc.

Relationship likelihood: Strong

Chief Scientific Officer at Agios Pharmaceuticals, Inc.

Relationship likelihood: Strong

Member, Scientific Advisory Board at Syros Pharmaceuticals, Inc.

Relationship likelihood: Strong

Paths to Nathanael Gray
Potential Connections via
Relationship Science
You
Nathanael Gray
Co-Founder at Syros Pharmaceuticals, Inc.
Education
Graduate
Class of 1991

Berkeley High School is a company that specializes in technical and language education services.

Ph.D in Organic Chemistry

University of California Berkeley National rankings: In a National Research Council analysis of 212 doctoral programs at American universities, 48 Berkeley programs place among the top 10 nationwide. Faculty awards and honors: There are 8 Nobel Laureates, 32 MacArthur Fellows, and 4 Pulitzer Prize winners among the current faculty. History of UC Berkeley: Historical highlights, arranged by topic, following the campus's development — from UC's founding in 1868 to a turn-of-the-century building boom, a research explosion in the 1930s, the Free Speech Movement of the '60s, and Berkeley's key role today in science and technology revolutions. Timeline of discoveries and contributions by UC Berkeley scholars. Traditions of Cal: Who was the Angel of Death? What's with the "Big C" up there in the hills — and why is it sometimes green? Who wears Oski's jolly bear head and size 54 yellow sweater? Tours and webcams: Check out what's happening on Sproul Plaza, the campus's true heart. See stunning live views of the Bay Area from the Lawrence Hall of Science's perch in the Berkeley hills. Chancellor and administration: Information on Chancellor Robert Birgeneau, Executive Vice Chancellor and Provost George W. Breslauer, and how the university is organized. Organizational charts are included. UC System overview and links: On the campuses, laboratories, and medical centers that comprise UC's public educational system, as well as UC's K-12 partnerships, economic impact, and agriculture and environmental resources.

Memberships
Associate Member

The Broad Institute evolved from a decade of informal and successful research collaborations among scientists in the MIT and Harvard communities. In 1990, the Whitehead Institute/MIT Center for Genome Research (WICGR) was founded, and it soon became an international leader in the field of genomics and a flagship of the Human Genome Project. As early as 1995, WICGR scientists recognized the need to bring the power of genomics to the understanding of human disease. It launched pilot projects in genomic medicine, forming an unofficial collaborative network among scientists from across MIT and Harvard who pioneered new approaches to cancer and human genetics. In parallel, Harvard Medical School-based scientists established the Institute of Chemistry and Cell Biology (ICCB) in 1998, to facilitate the pursuit of chemical genetics as an academic discipline and a tool to further understand human biology and disease. In 2002, the ICCB was awarded an Initiative for Chemical Genetics (ICG) grant from the National Cancer Institute, and its successful Investigator-Initiated Screening Program facilitated small molecule screening projects for more than 80 research groups worldwide. These projects demonstrated the power of enabling scientists to collaborate to tackle the major challenges in molecular medicine. It was clear that a new type of formal organization was required — open, collaborative, interdisciplinary, and able to organize projects at any scale. In addition, it was important that the complementary expertise of the genomic scientists and the chemical biologists across MIT and Harvard be brought together in one place to drive the transformation of medicine with molecular knowledge. Discussions in 2002-2003 among Eli and Edythe Broad, MIT, Harvard and its affiliated hospitals, and the Whitehead Institute shaped the vision for this new institute. The extraordinary generosity of Eli and Edythe Broad, through their founding gift of $100 million (later doubled to $200 million) made it possible to formally announce the new institute in June 2003 and to launch it in May 2004. Less than four years after its launch, the Broads gave an unprecedented gift of $400 million in September 2008 to permanently endow the institute, providing long-term sustainability for its unique model of collaborative, inter-institutional research.

Career History
Co-Founder
2011 - Current

Syros Pharmaceuticals, Inc. engages in the development of gene control therapies for cancer and diseases. Its product candidates include SY-1425 and SY-5609. The company was founded by Richard A. Young, Nathanael S. Gray, and James E. Bradner on November 9, 2011 and is headquartered in Cambridge, MA.

Principal Investigator, Nathanael Gray Lab
Current

Since its founding in 1947, Dana-Farber has been committed to providing adults and children with cancer with the best treatment available today while developing tomorrow's cures through cutting-edge research. Read about our history, our breakthroughs, and the resources that help us support the health of our neighborhoods and communities.

Nancy Lurie Marks Professor of Biological Chemistry & Molecular Pharmacology in the Field of Medical Oncology
Current

Harvard Medical School (HMS) is the graduate medical school of Harvard University. It is located in the Longwood Medical Area of the Mission Hill neighborhood of Boston, Massachusetts.The school was founded by John Warren on September 19, 1782, with Benjamin Waterhouse, and Aaron Dexter.

Investments
Details Hidden

Petra Pharma Corp. operates as a drug development company that develops novel small molecules for the treatment of cancer and metabolic diseases. The company was founded by Lewis Clayton Cantley and Nathanael S. Gray in 2016 and is headquartered in New York, NY.

Details Hidden

C4 Therapeutics, Inc. provides new class of targeted protein degradation. It develops Degronimid platform that incorporates small molecule binders to target disease-causing proteins and facilitate their destruction and clearance from the cell through the natural ubiquitin and proteasome system. The company was founded by James E. Bradner, Kenneth C. Anderson, Nathanael S. Gray and Marc A. Cohen in October 2015 and is headquartered in Cambridge, MA.

Details Hidden

Syros Pharmaceuticals, Inc. engages in the development of gene control therapies for cancer and diseases. Its product candidates include SY-1425 and SY-5609. The company was founded by Richard A. Young, Nathanael S. Gray, and James E. Bradner on November 9, 2011 and is headquartered in Cambridge, MA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Nathanael Gray. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Nathanael Gray's profile does not indicate a business or promotional relationship of any kind between RelSci and Nathanael Gray.